Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo

被引:35
作者
Katunuma, N [1 ]
Matsui, A
Inubushi, T
Murata, E
Kakegawa, H
Ohba, Y
Turk, D
Turk, V
Tada, Y
Asao, T
机构
[1] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan
[2] Inst Taiho Pharmaceut Co, Hanno, Japan
[3] Jozef Stefan Inst, Dept Biochem, Ljubljana, Slovenia
[4] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
关键词
vitamin B-6; cathepsin K; cathepsin S; pyridoxal derivatives; pyridoxal phosphate;
D O I
10.1006/bbrc.1999.1953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found that pyridoxal phosphate shows considerable inhibition of cathepsins. CLIK-071, in which the phosphate ester of position 3 of pyridoxal phosphate was replaced by propionate, strongly inhibited cathepsin B. Three new types of synthetic pyridoxal propionate derivatives showing specific inhibition of cathepsin K were developed. New synthetic pyridoxal propionate derivatives, -162, -163, and -164, in which the methyl arm of position 6 of CLIK-071 was additionally modified, strongly inhibited cathepsin K and cathepsin S weakly, but other cathepsins were not inhibited. CLIK-166, in which the position 4 aldehyde of CLIK-071 is replaced by a vinyl radical and position 5 is additionally modified, showed cathepsin K-specific inhibition at 10(-5) M. Pit formation due to bone collagen degradation by cathepsin K of rat osteoclasts was specifically suppressed by administration of CLIK-164, but not by inhibitors of cathepsin L or B. (C) 2000 Academic Press.
引用
收藏
页码:850 / 854
页数:5
相关论文
共 22 条
[1]  
BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
[2]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[3]  
INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P86
[4]  
INOUE C, 1989, J BIOL CHEM, V264, P4747
[5]   SPECIFIC ASSAY-METHOD FOR THE ACTIVITIES OF CATHEPSIN L-TYPE CYSTEINE PROTEINASES [J].
INUBUSHI, T ;
KAKEGAWA, H ;
KISHINO, Y ;
KATUNUMA, N .
JOURNAL OF BIOCHEMISTRY, 1994, 116 (02) :282-284
[6]   MOLECULAR-CLONING AND SEQUENCING OF CDNA FOR RAT CATHEPSIN-L [J].
ISHIDOH, K ;
TOWATARI, T ;
IMAJOH, S ;
KAWASAKI, H ;
KOMINAMI, E ;
KATUNUMA, N ;
SUZUKI, K .
FEBS LETTERS, 1987, 223 (01) :69-73
[7]   STRUCTURE, PROPERTIES, MECHANISMS, AND ASSAYS OF CYSTEINE PROTEASE INHIBITORS - CYSTATINS AND E-64 DERIVATIVES [J].
KATUNUMA, N ;
KOMINAMI, E .
BIOTHIOLS, PT A: MONOTHIOLS AND DITHIOLS, PROTEIN THIOLS, AND THIYL RADICALS, 1995, 251 :382-397
[8]   Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo [J].
Katunuma, N ;
Murata, E ;
Kakegawa, H ;
Matsui, A ;
Tsuzuki, H ;
Tsuge, H ;
Turk, D ;
Turk, V ;
Fukushima, M ;
Tada, Y ;
Asao, T .
FEBS LETTERS, 1999, 458 (01) :6-10
[9]   Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli [J].
Kopitar, G ;
Dolinar, M ;
Strukelj, B ;
Pungercar, J ;
Turk, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02) :558-562
[10]  
KORTYNK W, 1967, J CHEM SOC, V10, P345